CLGN: Prakiraan pendapatan perusahaan CollPlant
The sales trend of CollPlant Biotechnologies (CLGN) underscores the company's success in developing plant-based collagen for cosmetology, where licenses guarantee a stable income stream. Currently, 0.00 reflects a new level. Growth is driven by the integration of rhCollagen into 3D tissue printing and surgery. Meanwhile, business resilience depends on partnerships with pharmaceutical behemoths and strict control of R&D expenditures.
Rincian analitis perusahaan CollPlant Biotechnologies
- nilai saham lan prakiraan konsensus rega:
- informasi kapitalisasi pasar:
- data ekuitas miturut neraca:
- statistik kawajiban utang lan likuiditas:
Total Utang marang Modal CollPlant Biotechnologies|CLGN - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas CollPlant Biotechnologies|CLGN - Utang agregat perusahaan|Utang marang nilai buku CollPlant|CLGN - Gedhene kewajiban jangka dawa|Kewajiban jangka cendhak perusahaan CollPlant Biotechnologies|Rasio cepet collplant.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
CLGN - Bathi resik perusahaan|Proyeksi bathi mangsa ngarep CollPlant Biotechnologies|CLGN - Periode bali modal bisnis|Rega marang bathi mangsa ngarep CollPlant Biotechnologies|CLGN - Rega marang bathi kanthi panyesuaian wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan CollPlant|CLGN - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi resik saben saham (EPS TTM) CollPlant Biotechnologies|CLGN - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan collplant.com|CLGN - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep CollPlant Biotechnologies
- indikator dodolan lan pendapatan:
Ringkesan analitik perusahaan:CollPlant Biotechnologies Ltd. CLGN
The revenue forecast for CollPlant Biotechnologies (CLGN) combines the potential of proprietary plant-based collagen with market demand dynamics. This metric filters out short-term volatility noise, extrapolating long-term trends through an analysis of biomedical contract execution cycles. By examining the company's future sales model, investors can see the expected scalability of the business. Seamless interaction with international laboratories minimizes operational risks, confirming the issuer's strong fundamental resilience.
Pesaing wigati
Prakiraan pendapatan perusahaan HCA Healthcare, Inc. (HCA)|Prakiraan pendapatan perusahaan THC (tenethealth.com)|Prakiraan pendapatan perusahaan Fresenius Medical Care AG & Co. KGaA FMS|Solventum Corp - Prakiraan pendapatan perusahaan|EHC - Prakiraan pendapatan perusahaan|Pendapatan sing dikarepake perusahaan UHS|DaVita Inc. (DVA) - Prakiraan pendapatan perusahaan|RDNT (radnet.com) - Prakiraan pendapatan perusahaan|OPCH (Option Care Health, Inc.) - Prakiraan volume dodolan|Prakiraan volume dodolan Surgery Partners Inc|Prakiraan pendapatan perusahaan Premier Corp (PINC)|America's Best Contacts & Eyeglasses - Prakiraan pendapatan perusahaan|Progyny, Inc. - Volume dodolan mangsa ngarep perusahaan|Prakiraan volume pendapatan perusahaan ARDT (ardenthealth.com)|SEM: Volume dodolan mangsa ngarep perusahaan|Pendapatan mangsa ngarep perusahaan ASTH (Astrana Health Inc)|MD: Prakiraan volume dodolan|USPH (U.S. Physical Therapy, Inc.) - Prakiraan pendapatan perusahaan|PNTG (The Pennant Group, Inc.) - Prakiraan volume dodolan|organogenesis.com (ORGO) - Dodolan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Nutex Health (NUTX)|AUNA - Volume dodolan sing dikarepake perusahaan|SBC Medical Group Holdings Inc. - Volume dodolan mangsa ngarep perusahaan|Prakiraan volume pendapatan perusahaan EOLS (Evolus Corp)|Community Health Systems - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan The Beauty Health|MDWD: Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan Biote|JYNT (The Joint Corporation) - Prakiraan volume dodolan|DCGO: Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan P3 Health Partners Inc. (PIII)|gaintherapeutics.com - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan EUDA Health Holdings Limited EUDA|Basel Medical (BMGL) - Volume dodolan sing dikarepake perusahaan|CUPR - Prakiraan pendapatan perusahaan|CCM: Prakiraan pendapatan perusahaan|American Shared Hospital (AMS) - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan medirom.co.jp (MRM)|ALBT (Avalon GloboCare Corp) - Prakiraan volume dodolan|DHAI - Prakiraan dodolan perusahaan|Prakiraan volume dodolan XAGE|Dodolan mangsa ngarep perusahaan NewGenIvf Corp|Prakiraan volume dodolan ATIP (ATI Physical Therapy, Inc.)|caremax.com (CMAX) - Volume dodolan sing dikarepake perusahaan|KDLY - Prakiraan pendapatan perusahaan|Dodolan mangsa ngarep perusahaan ModivCare Inc MODV|NVOS: Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan SunLink Health Systems, Inc.|Prakiraan pendapatan perusahaan IMAC Holdings, Inc.
